Manager × security

Privium Fund Management B.V. IONS holdings history

Who else holds this security? →

IONIS PHARMACEUTICALS INC · CUSIP 462222100 · CIK 1795097

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Privium Fund Management B.V. reported 319.92K IONS (shares), valued at $25.37M, or 4.66% of its reported non-derivative portfolio. Filed 2026-08-07.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
4.66%
Shares
319.92K
319,924
Reported value
$25.37M
USD

Shares increased 10.31%; reported value increased 16.48%, and weight changed +0.13 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20264.66%319,924SEC filing ↗Filed Aug 7, 2026
Q1 20264.53%290,024SEC filing ↗Filed May 5, 2026
Q4 20253.51%240,824SEC filing ↗Filed Feb 3, 2026
Q3 20252.93%248,894SEC filing ↗Filed Nov 4, 2025
Q2 20252.31%267,594SEC filing ↗Filed Jul 30, 2025
Q1 20252.10%267,594SEC filing ↗Filed May 9, 2025
Q4 20242.11%266,794SEC filing ↗Filed Feb 11, 2025
Q3 20242.50%250,744SEC filing ↗Filed Nov 1, 2024
Q2 20242.85%247,267SEC filing ↗Filed Aug 1, 2024
Q1 20242.63%226,993SEC filing ↗Filed Apr 30, 2024
Q4 20233.20%217,493SEC filing ↗Filed Feb 26, 2024Amended

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20233.20%217,493$11.50MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 26, 2024
Q1 20242.63%226,993$9.84MShares increased 4.37%; reported value decreased 14.42%, and weight changed -0.57 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 30, 2024
Q2 20242.85%247,267$11.16MShares increased 8.93%; reported value increased 13.43%, and weight changed +0.22 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 1, 2024
Q3 20242.50%250,744$10.04MShares increased 1.41%; reported value decreased 10.01%, and weight changed -0.35 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 1, 2024
Q4 20242.11%266,794$9.33MShares increased 6.40%; reported value decreased 7.14%, and weight changed -0.39 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 11, 2025
Q1 20252.10%267,594$8.07MShares increased 0.30%; reported value decreased 13.44%, and weight changed -0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 9, 2025
Q2 20252.31%267,594$10.69MShares unchanged; reported value increased 32.38%, and weight changed +0.21 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 30, 2025
Q3 20252.93%248,894$16.28MShares decreased 6.99%; reported value increased 52.35%, and weight changed +0.62 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 4, 2025
Q4 20253.51%240,824$19.05MShares decreased 3.24%; reported value increased 17.01%, and weight changed +0.58 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 3, 2026
Q1 20264.53%290,024$21.78MShares increased 20.43%; reported value increased 14.31%, and weight changed +1.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 5, 2026
Q2 20264.66%319,924$25.37MShares increased 10.31%; reported value increased 16.48%, and weight changed +0.13 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 7, 2026
Privium Fund Management B.V. · IONIS PHARMACEUTICALS INC

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1795097","quarter":"2026Q2","cusip":"462222100"}

get_institutional_manager_history
{"cik":"1795097","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.